期刊文献+

伏立康唑联合小剂量糖皮质激素治疗儿童隐球菌性脑膜炎:2例报道并文献复习 被引量:4

Voriconazole with low dose of glucocorticosteroid for the treatment of cryptococcal meningitis in children:2 case reports and literature review
下载PDF
导出
摘要 目的探讨伏立康唑联合小剂量糖皮质激素对儿童隐球菌性脑膜炎的疗效。方法分析2例采用伏立康唑联合小剂量糖皮质激素治疗的儿童隐球菌性脑膜炎病例并进行相关文献复习。结果患儿经治疗后头痛等症状消失,颅内压逐渐下降至正常水平,脑脊液蛋白水平明显下降并稳定。结论伏立康唑联合小剂量糖皮质激素能迅速有效地控制临床症状,使用方便、副作用小,可作为儿童隐球菌性脑膜炎诱导治疗的一种选择。 Objective To explore the effect of voriconazole and glucocorticosteroid for the treatment of cryptococcal meningitis in children.Methods Manifestation,intracranial pressure and protein production in cerebrospinal fluid of the 2 patients with cryptococcal meningitis after the treatment were analyzed.Results The intracranial pressure and protein production in cerebrospinal fluid decreased and stabilized in normal range after 4-week treatment.Conclusions Voriconazole combinatied with low dose of glucocorticosteroid was effective for cryptococcal meningitis in children with convenience and fewer side effects.
出处 《中国真菌学杂志》 2010年第4期214-217,共4页 Chinese Journal of Mycology
基金 国家自然科学基金(30972817)
关键词 隐球菌性脑膜炎 儿童 伏立康唑 糖皮质激素 cryptococcal meningitis children voriconazole glucocorticosteroid
  • 相关文献

参考文献16

  • 1McCahy KM,Morgan J,Wannemuehler KA,et al.Populationbased surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence[J].AIDS,2006,20(17):2199-2206.
  • 2Morgan J,McCarthy KM,Gould S,et al.Cryptococcus gattii infection:characteristics and epidemiology of cases identified in a South African province with high HIV sero prevalence,2002-2004[J].Clin Infect Dis,2006,43(8):1077-1080.
  • 3徐楠,朱元杰,陈江汉,温海,顾菊林.儿童隐球菌性脑膜炎临床分析[J].中国真菌学杂志,2009,4(1):24-25. 被引量:11
  • 4顾菊林,温海,廖万清.儿童隐球菌性脑膜炎(附8例报告)[J].第二军医大学学报,2002,23(12):1344-1344. 被引量:3
  • 5Perfect JR,Dismukes WE,Dromer F,et al.Clinical practice guidelines for the management of cryptoceccal disease:2010 update by the Infectious Diseases Society of America[J].Clin Infect Dis,2010,50(3):291-322.
  • 6Pfaller MA,J Zhang,Messer SA,et al.In vitro activities of voriconazole,fluconazole,and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa[J].Antimicrob Agents Chemother,1999,43(1):169-171.
  • 7Pfaller MA,Messer S A,Boyken L,et al.Global trends in the antifungal susceptibility of Cryptococcus neoformans(1990 to2004)[J].J Clin Microbiol,2005,43(5):2163-2167.
  • 8Pfaller MA,Messer SA,Boyken L,et al.In vitro activities of vericonazole,posaconazole,and fluconazole against 4,169 clinical isolates of Candida spp.and Crypwcoccus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program[J].Diagn Microbiol Infect Dis,2004,48(3):201-205.
  • 9Pfaller MA,Diekema DJ,Gibbs DL,et al.Results from the ARTEMIS DISK global antifungal surveillance study,1997 to2007:10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing[J].J Clin Microbiol,2009,47(1):117-123.
  • 10Yildiran ST,Fothergill AW,Sutton DA,et al.In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole,voriconazole and pesaconazole(SCH56592)[J].Mycoses,2002,45(9-10):378-383.

二级参考文献15

  • 1顾菊林,温海,陈江汉,陈裕充,李军城.隐球菌性脑膜炎39例临床分析[J].临床皮肤科杂志,2005,34(12):801-803. 被引量:9
  • 2姚志荣,廖万清,温海,李志刚,陈江汉,吴建华,桂杏元,顾菊林.隐球菌性脑膜炎的治疗研究[J].中华皮肤科杂志,1996,29(5):324-326. 被引量:15
  • 3沈银忠,卢洪洲,张永信.HIV/AIDS合并深部真菌感染[J].中国艾滋病性病,2006,12(4):379-381. 被引量:21
  • 4Jamie M, Rappaport J, Bhatt S, et al. Prevention of hearing loss in experimental pneumococeal meningitis by administration of dexamethasone and ketorolac. J Infect Dis, 1999, 179:264-268.
  • 5Altschuler RA, Cho Y, Ylikoski J. Rescue and regrowth of sensory nerves following deafferentation by neurotrophic factors.Ann-N-Y-Acad-Sci, 1999, 884 : 305-311.
  • 6Barbany G, Persson H. Adrenalectomy attenuates kainic acidelicited increases of messenger RNAs for neurotrophins and their receptors in the rat brain. Neuroseience, 1993, 54 : 909-922.
  • 7Vellucci SV, Parrott RF, Mimmack ML. Down-regulation of BDNF mRNA, with no effect on TrkB or glucocortieoid receptor mRNAs, in the porcine hippocampus after acute dexamethasone treatment. Res-Vet-Sci, 2001, 70; 157-162.
  • 8Grundy PL, Patel N, Harbuz MS,et al. Glucocorticoids modulate BDNF mRNA expression in the rat hippocampus after traumaticbrain injury. Neuroreport, 2000, 11 : 3381-3384.
  • 9Aloe L, Properzi F, Probert L, et al. Learning abilities, NGF and BDNF brain levels in two lines of TNF-alpha transgenic mice,one characterized by neurological disorders, the other phenotypically normal. Brain-Res, 1999,840(12) : 125-137.
  • 10Lapchak PA, Aranjio DM, Hefti F. System interleukin-1 b decrease brain derived neurotrophic factor mRNA expression in the rat hippocampal formation. Neuroscience, 1993,53 : 297-301.

共引文献31

同被引文献52

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部